Drugs Misuse Amendment Regulation (No. 1) 2013 (Qld)
Case
No judgment structure available for this case.
Queensland Drugs Misuse Amendment Regulation (No. 1) 2013 Subordinate Legislation 2013 No. 41 made under the DrugsMisuseAct1986 Contents Page 1 Short title . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 2 Regulation amended . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 3 Amendment of sch 1 (Dangerous drugs) . . . . . . . . . . . . . . . . . . . 2 4 Amendment of sch 2 (Dangerous drugs) . . . . . . . . . . . . . . . . . . . 2 5 Amendment of sch 3 (Specified quantities for particular dangerous drugs) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 6 Amendment of sch 4 (Specified quantities for particular dangerous drugs) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
Drugs Misuse Amendment Regulation (No. 1) 2013 [s 1] 1 Short title This regulation may be cited as the Drugs Misuse Amendment Regulation (No. 1) 2013 . 2 Regulation amended This regulation amends the Drugs Misuse Regulation 1987. 3 Amendment of sch 1 (Dangerous drugs) (1) Schedule 1, heading, ‘7, 8, 8A, 9, 10, 11’— omit, insert— 8, 8A, 9 (2) Schedule 1— insert— Paramethoxymethamphetamine (PMMA) 4 Amendment of sch 2 (Dangerous drugs) (1) Schedule 2, heading, after ‘ drug ,’— insert— 4A, (2) Schedule 2— insert— N-(1-Adamantyl)-1-pentyl-indazole-3-carboxamide (APINACA or AKB48) Alpha-Pyrrolidinovalerophenone (alpha-PVP) 2-Aminoindane 6-(2-Aminopropyl)benzofuran (6-APB) 1-Butyl-3-(2-methoxybenzoyl)indole (RCS-4(C4) 2-methoxy isomer) [3-(3-Carbamoylphenyl)phenyl] N-cyclohexylcarbamate (URB-597) Cyclohexyl [1,1'-biphenyl]-3-ylcarbamate (URB-602) Desoxypipradrol (2-DPMP) Page 2 2013 SL No. 41
Drugs Misuse Amendment Regulation (No. 1) 2013 [s 4] 1,3-Dimethylamylamine (DMAA or methylhexanamine) 1-(5-Fluoropentyl)-3-(1-adamantylamido)indole (STS-135) (1-(5-Fluoropentyl)-indol-3-yl)-(2,2,3,3-tetramethylcyclopropyl) methanone (XLR-11; 5-Fluoro UR-144) 1-(5-Fluoropentyl)-3-(4-methyl-1-naphthoyl)indole (5-Fluoro JWH-122) 5-Hydroxy tryptophan (5-HTP) 4-Hydroxy-N-methyl-N-ethyltryptamine (4-HO-MET) Methiopropamine Methoxetamine N-(2-Methoxybenzyl)-2,5-dimethoxy-4-bromophenethylamine (25B-NBOMe) N-(2-Methoxybenzyl)-2,5-dimethoxy-4-chlorophenethylamine (25C-NBOMe) N-(2-Methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (25I-NBOMe) 5-Methoxy-N,N-diallyltryptamine (5-MeO-DALT) 5,6-Methylenedioxy-2-aminoindane (MDAI) 3,4-Methylenedioxypyrovalerone (MDPV) 4-Methylethylcathinone (4-MEC) 1-[(N-Methylpiperidin-2-yl)methyl]-3-(1-adamantoyl)indole (AM-1248) 1-[(N-Methylpiperidin-2-yl)methyl]-3-(2-iodobenzoyl)indole (AM-2233) 1-[(N-Methylpiperidin-2-yl)methyl]-3-(4-methyl-1-naphthoyl)indole (MAM-1220) 1-[(N-Methylpiperidin-2-yl)methyl]-3-(1-naphthoyl)indole (AM-1220) Naphthylpyrovalerone (Naphyrone) 1-Pentyl-3-(1-adamantoyl)indole (AB-001) (1-Pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone (UR-144) 1-Pentyl-3-(2-methoxybenzoyl)indole (RCS-4 (2-methoxy isomer)) Phenazepam 2013 SL No. 41 Page 3
Drugs Misuse Amendment Regulation (No. 1) 2013 [s 5] 5 Amendment of sch 3 (Specified quantities for particular dangerous drugs) (1) Schedule 3, heading, ‘4,’— omit. (2) Schedule 3— insert— Paramethoxymethamphetamine (PMMA) 2.0g 6 Amendment of sch 4 (Specified quantities for particular dangerous drugs) Schedule 4— insert— Paramethoxymethamphetamine (PMMA) 200.0g ENDNOTES 1 Made by the Governor in Council on 4 April 2013. 2 Notified in the gazette on 5 April 2013. 3 Laid before the Legislative Assembly on . . . 4 The administering agency is the Department of Justice and Attorney-General. © State of Queensland 2013 Authorised by the Parliamentary Counsel Page 4 2013 SL No. 41
Actions
Download as PDF
Download as Word Document
Cases Citing This Decision
0
Cases Cited
0
Statutory Material Cited
0